Is compliance slowing down your medical device development, or are you using it to outpace the competition? In this interview from the Med-Tech Expo 2026 show floor, Tarn Brown from Columbus shares practical strategies for turning regulatory requirements into a true competitive advantage. From debun
Oticon has announced the launch of Oticon Reveal, what it says is the “world’s first” hearing aid powered by Dual AI, designed to deliver crystal-clear speech and meaningful sounds in optimal balance, bringing hearing aid users closer to a natural hearing experience according to the company. Built o
Bracco Imaging has announced that VueJect, its first dedicated ultrasound contrast delivery system engineered to support cardiology imaging specifically, has received 510(k) clearance from the FDA and authorisation from Health Canada. The company says these regulatory milestones represent the first
The Shelford Group has announced a major expansion of its Surgical Training in Advanced Robotic Technology (START) programme, extending accredited, platform-agnostic robotic surgery training to surgical trainees across the South East of England. Already available in the North East, North West and Ea
NIPRO, through its subsidiary Nipro Medical Corporation, has announced the U.S. commercial launch of ELISIO-HX, a medium-cutoff dialyser featuring super high-flux membrane technology. Enabled by the recent FDA 510(k) clearance of ELISIO-HX, NIPRO is introducing its expanded hemodialysis approach wit
A new narrative review by Imperial Brands Science published in the peer-reviewed academic literature brings together a broad body of scientific evidence to assess how next generation nicotine products (NGP), including vapes, oral nicotine pouches and heated tobacco, may affect cardiovascular health
Chris Whitehouse, a political consultant and expert on medical technology policy and regulation at Whitehouse Communications, who played a key role in securing the government’s commitment to introducing Value Based Procurement (VBP) across the NHS in England, sets out some of the key steps to its de
Claret Capital Partners, one of Europe’s largest independent growth debt fund managers has made an investment through its funds, of €30m in Carvolix, formerly Affluent Medical. Carvolix is a French commercial- and clinical-stage medical technology company specialising in the international developmen
Dr Sarah Rudebeck, a senior NHS clinical psychologist, has won a £75,000 Innovate UK Women in Innovation Award to build an AI learning tool for pupils with special educational needs and disabilities (SEND). She is one of 61 award winners, selected from a record 1,590 applications. According to the t
Following World Lung Cancer Day, RevealDx, a leader in AI characterisation of lung nodules, has announced a distribution agreement and strategic investment of $3.4 million by 4DMedical, expanding access to its flagship product, RevealAI-Lung. RevealAI-Lung has received MDR Certification, TGA Approva
Mahesh Wale, UK&I Business Unit Head for Retail, Consumer Goods, Travel, Hospitality, and Life Science at Cognizant explores how the growing focus on AI regulation is changing the way MedTech companies approach innovation For several years, AI has been viewed as one of the biggest opportunities for
BlueWind Medical, Ltd., a leader in Implantable Tibial Neuromodulation (ITNM) and developer of the Revi System, a patient-centric solution for urgency urinary incontinence (UUI), has announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for Revi Extend. The company
